Supernus (SUPN) Common Equity (2011 - 2026)
Supernus Pharmaceuticals (SUPN) reported Common Equity of $1.06 billion for Q3 2026, up 1.2% from $1.05 billion a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) Common Equity (2011 - 2026) Analysis & Trends
Dating back to Q4 2011, Supernus Pharmaceuticals' Common Equity record includes 60 quarters.
- Common Equity has increased for 12 consecutive years, with a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- By year, Common Equity came in at $1.04 billion in FY2024 (+12.4%), $921.52 million in FY2023 (+4.0%), $886.2 million in FY2022 (+8.6%) and $815.85 million in FY2021 (+9.5%).
- Five-year quarterly Common Equity spans a low of $815.85 million in Q4 2021 and a high of $1.08 billion in Q1 2026.
- Year over year, Common Equity gained in seven of the last eight quarters, with growth averaging 5.5%.
- The high point for year-over-year Common Equity in five years was Q4 2024 (growth of 12.4%); the low point was Q2 2026 (a decline of 3.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.03 billion (Q2 2026), $1.08 billion (Q1 2026) and $1.06 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Supernus | 1.62 Bn | 196.50 Mn | 199.75 Mn | 1.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.06 Bn |
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 1.06 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.01 Bn |
| Jun 30, 2024 | 957.45 Mn |
| Mar 31, 2024 | 929.17 Mn |
| Dec 31, 2023 | 921.52 Mn |
| Sep 30, 2023 | 912.19 Mn |
| Jun 30, 2023 | 919.91 Mn |
| Mar 31, 2023 | 912.15 Mn |
| Dec 31, 2022 | 886.20 Mn |
| Sep 30, 2022 | 852.80 Mn |
| Jun 30, 2022 | 841.43 Mn |
| Mar 31, 2022 | 828.45 Mn |
| Dec 31, 2021 | 815.85 Mn |
API Access
Supernus Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();